VYNE Therapeutics Inc. (NASDAQ: VYNE) Stock Information | RedChip

VYNE Therapeutics Inc. (NASDAQ: VYNE) Listen to this Section


$1.88
+0.1500 ( +8.67% ) 43.9K

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Market Data


Open


$1.88

Previous close


$1.73

Volume


43.9K

Market cap


$27.02M

Day range


$1.71 - $1.87

52 week range


$1.57 - $5.14

Insider Ownership Transactions

Total Amount Purchased: -47,153.00 | $ -88,647.64

Date Type Amount Purchased Purchaser
2024-07-03 Sale -935.00 Domzalski David
2024-07-03 Sale -92.00 Zeronda Tyler
2024-07-03 Sale -138.00 Stuart Iain
2024-07-03 Sale -143.00 Harsch Mutya
2024-06-04 Sale -4429.00 Domzalski David
2024-04-03 Sale -157.00 Stuart Iain
2024-04-03 Sale -161.00 Harsch Mutya
2024-04-03 Sale -1004.00 Domzalski David
2024-04-03 Sale -94.00 Zeronda Tyler
2024-01-03 Sale -40000.00 Borowski Christine

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 14, 2024
10-q Quarterly Reports 57 Aug 14, 2024
4 Insider transactions 1 Jul 03, 2024
4 Insider transactions 1 Jul 03, 2024
4 Insider transactions 1 Jul 03, 2024
4 Insider transactions 1 Jul 03, 2024
4 Insider transactions 1 Jun 04, 2024
8-k 8K-related 15 May 09, 2024
10-q Quarterly Reports 57 May 09, 2024
4 Insider transactions 1 Apr 03, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.